📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer. (2017)

First Author: Pishvaian MJ

Attributed to: Glasgow Molecular Pathology (GMP) Node funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/bjc.2017.40

PubMed Identifier: 28291774

Publication URI: http://europepmc.org/abstract/MED/28291774

Type: Journal Article/Review

Volume: 116

Parent Publication: British journal of cancer

Issue: 8

ISSN: 0007-0920